Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| IPV | POLIO VIRUS, INACT. (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | X1D141M | OT |
| TDAP | TDAP (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UT976AA | OT |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | Y007193 | OT |
No adverse event; Improper storge of product in use; This spontaneous report was received from a consumer or and refers to a 10-year-old male patient. The patient's medical history, concomitant therapies were not reported. The patient's concurrent condition included autism. On 23-Oct-2024, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (lot #Y007193, expiration date: 06-Jun-2026) administered by intramuscular route as prophylaxis (strength and dose were not provided); Tdap (Diphtheria vaccine toxoid;Pertussis vaccine acellular;Tetanus vaccine toxoid) (lot #UT976AA, expiration date: 03-Oct-2026) administered by intramuscular route for an unknown indication (strength and dose were not provided); and Ipv (Polio vaccine inact) (lot #X1D141M, expiration date: 31-Oct-2026) administered by intramuscular route for an unknown indication (strength and dose were not provided) after temperature excursion (TE) (Product storage error). Fridge temperature dropped below freezing over the weekend while office was closed. Temperature was 25F, time frame was 1 hour. No additional adverse event (AE) (No adverse event).
Autism